The Daily Buyout
$34M 2027 revenueStrategic acquisitionHealthcare & Life SciencesCompleted

Axogen closes BioCircuit Technologies deal for NerveTape

Axogen completed its acquisition of BioCircuit Technologies, maker of the first FDA-cleared sutureless nerve repair device, expected to add about $34 million to 2027 revenue.

Read the full coverage, free

We only link to sources you can read without a subscription. How we check.

Following healthcare M&A?

The next big healthcare deal will be in our email the morning after it's announced, with the rest of the day's biggest deals. Free, with no paywalled links.

Free · Unsubscribe anytime

See what you get →